رجوع
نطاق اليوم
KWD 103.78
KWD 107.17
نطاق 52 أسبوعًا
KWD 73.16
KWD 130.23
حجم التداول
630,887
متوسط 50 يوم / 200 يوم
KWD 113.40
/
KWD 99.38
الإغلاق السابق
KWD 106.84
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -32.6 | 0.3 |
| P/B | 9.3 | 2.9 |
| ROE % | -26.4 | 3.7 |
| Net Margin % | -37.0 | 3.8 |
| Rev Growth 5Y % | 14.6 | 10.0 |
| D/E | 0.2 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 143.440
+36.3%
Low: KWD 127.000
High: KWD 165.000
ربحية السهم المستقبلية
-KWD 0.564
الإيرادات المقدّرة
610 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 4.320
KWD 4.134 – KWD 4.481
|
1.5 B | 2 |
| FY2029 |
KWD 2.620
KWD 2.507 – KWD 2.718
|
1.3 B | 4 |
| FY2028 |
KWD 1.563
KWD 1.174 – KWD 2.124
|
1 B | 6 |
النقاط الرئيسية
Revenue grew 14.62% annually over 5 years — strong growth
Debt/Equity of 0.21 — conservative balance sheet
Negative free cash flow of -54.01M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 17.71%
Capital efficient — spends only 1.51% of revenue on capex
النمو
Revenue Growth (5Y)
14.62%
Revenue (1Y)32.33%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-26.38%
ROIC-18.81%
Net Margin-36.99%
Op. Margin-39.33%
الأمان
Debt / Equity
0.21
Current Ratio4.69
Interest Coverage-43.06
التقييم
P/E Ratio
-32.56
P/B Ratio9.31
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 32.33% | Revenue Growth (3Y) | 26.98% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 14.62% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 507.44M | Net Income (TTM) | -187.69M |
| ROE | -26.38% | ROA | -21.01% |
| Gross Margin | 55.72% | Operating Margin | -39.33% |
| Net Margin | -36.99% | Free Cash Flow (TTM) | -54.01M |
| ROIC | -18.81% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.21 | Current Ratio | 4.69 |
| Interest Coverage | -43.06 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -32.56 | P/B Ratio | 9.31 |
| P/S Ratio | 12.04 | PEG Ratio | -1.87 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 6.11B | Enterprise Value | 6.16B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 507.44M | 383.48M | 314.71M | 282.86M | 294.01M |
| Net Income | -187.69M | -146.37M | -134.66M | -99.20M | -49.59M |
| EPS (Diluted) | -3.28 | -2.77 | -2.78 | -2.09 | -1.07 |
| Gross Profit | 282.76M | 289.45M | 239.14M | 213.88M | 227.38M |
| Operating Income | -199.60M | -122.37M | -128.70M | -82.31M | -32.87M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 893.49M | 974.76M | 940.41M | 1.07B | 1.13B |
| Total Liabilities | 237.33M | 207.83M | 478.65M | 544.16M | 541.68M |
| Shareholders' Equity | 656.16M | 766.93M | 461.77M | 530.01M | 587.15M |
| Total Debt | 139.64M | 105.87M | 383.74M | 382.91M | 383.39M |
| Cash & Equivalents | 90.81M | 169.63M | 93.47M | 119.53M | 100.71M |
| Current Assets | 474.98M | 449.79M | 395.46M | 443.86M | 486.13M |
| Current Liabilities | 101.28M | 75.13M | 74.01M | 72.36M | 63.36M |